Plasmodium vivax in the era of the shrinking P. falciparum map

RN Price, RJ Commons, KE Battle, K Thriemer… - Trends in …, 2020 - cell.com
Plasmodium vivax is an important cause of malaria, associated with a significant public
health burden. Whilst enhanced malaria-control activities have successfully reduced the …

Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis

RJ Commons, M Rajasekhar, P Edler… - The Lancet Infectious …, 2024 - thelancet.com
Background Primaquine is used to eliminate Plasmodium vivax hypnozoites, but its optimal
dosing regimen remains unclear. We undertook a systematic review and individual patient …

Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites

SV Siegel, H Trimarsanto, R Amato, K Murie… - Nature …, 2024 - nature.com
Challenges in classifying recurrent Plasmodium vivax infections constrain surveillance of
antimalarial efficacy and transmission. Recurrent infections may arise from activation of …

Can the future of ID escape the inertial dogma of its past? The exemplars of shorter is better and oral is the new IV

K Davar, D Clark, RM Centor… - Open Forum …, 2023 - academic.oup.com
Like all fields of medicine, Infectious Diseases is rife with dogma that underpins much
clinical practice. In this study, we discuss 2 specific examples of historical practice that have …

Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis

M Rajasekhar, JA Simpson, B Ley, P Edler… - The Lancet Infectious …, 2024 - thelancet.com
Background Primaquine radical cure is used to treat dormant liver-stage parasites and
prevent relapsing Plasmodium vivax malaria but is limited by concerns of haemolysis. We …

[HTML][HTML] Estimating the proportion of Plasmodium vivax recurrences caused by relapse: a systematic review and meta-analysis

RJ Commons, JA Simpson, J Watson… - The American journal …, 2020 - ncbi.nlm.nih.gov
Plasmodium vivax and Plasmodium ovale form dormant liver hypnozoites that can reactivate
weeks to months following initial infection. Malaria recurrences caused by relapses are an …

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis

JA Watson, RJ Commons, J Tarning, JA Simpson… - Elife, 2022 - elifesciences.org
Tafenoquine is a newly licensed antimalarial drug for the radical cure of Plasmodium vivax
malaria. The mechanism of action and optimal dosing are uncertain. We pooled individual …

[HTML][HTML] Plasmodium vivax–How hidden reservoirs hinder global malaria elimination

F Angrisano, LJ Robinson - Parasitology International, 2022 - Elsevier
Plasmodium vivax is the most geographically widespread human malaria parasite. Global
malaria efforts have been less successful at reducing the burden of P. vivax compared to P …

8-Aminoquinoline therapy for latent malaria

JK Baird - Clinical Microbiology Reviews, 2019 - Am Soc Microbiol
The technical genesis and practice of 8-aminoquinoline therapy of latent malaria offer
singular scientific, clinical, and public health insights. The 8-aminoquinolines brought …

Advances and roadblocks in the treatment of malaria

B Hanboonkunupakarn, NJ White - British journal of clinical …, 2022 - Wiley Online Library
The deployment of artesunate for severe malaria and the artemisinin combination therapies
(ACTs) for uncomplicated malaria has been a major advance in antimalarial therapeutics …